Late Phase & Outcome Research

Observational, Non-Interventional Studies/Phase IV Research Post-approval, observational studies can be used to address

Late Phase and Outcomes Research


With a track record for successful analysis and extensive scientific publication, the ICON Late Phase & Outcomes Research division delivers high-impact evidence that explores and demonstrates the value of pharmaceutical, biotechnology, consumer healthcare and medical device products in all global markets, with a focus on maximising return on investment